Fondation du Centre de Chimiothérapie Anti Cancéreuse

What Fondation du Centre de Chimiothérapie Anti Cancéreuse does

Fondation du Centre de Chimiothérapie Anti Cancéreuse is a Swiss foundation (Fondation) registered in Lausanne, Switzerland, with a stated mission tied to anti-cancer chemotherapy. The organization operates with a very small team of approximately 6 employees, consistent with a non-profit or specialized clinical/research foundation rather than a commercial enterprise. The legal name indicates a center focused on anti-cancer chemotherapy, suggesting activities in oncology treatment, clinical care, or related research and patient support.

The source data provides no substantive detail on products, services, technology stack, revenue model, customer segments, leadership, partnerships, or operational history. The Foundation's website (ccac.ch) returns only a loader/verification page with no disclosed content, and no third-party sources surfaced operational, financial, or strategic information. There is no evidence of commercial pricing, product launches, funding rounds, M&A activity, or regulatory actions attributable to the entity in the provided corpus.

Given the foundation structure, very small headcount, and absence of disclosed revenue mechanics, the entity most plausibly operates on grants, donations, and/or limited clinical or research services. The lack of verifiable operational and financial data is the primary analytical constraint, and any deeper characterization of business model, addressable market, or competitive positioning requires primary-source verification through Swiss Registry of Commerce filings, Foundation Supervisory Authority records, or direct outreach.

Name

Fondation du Centre de Chimiothérapie Anti Cancéreuse

Legal name

Fondation du Centre de Chimiothérapie Anti Cancéreuse

Website

https://ccac.ch

Company type

Private

Headcount range

1–10 employees

Short description

Fondation du Centre de Chimiothérapie Anti Cancéreuse is a Swiss foundation based in Lausanne, focused on anti-cancer chemotherapy, operating with a small team of approximately 6 employees.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Cancer chemotherapy services
• Oncology treatment center
• Ambulatory cancer care
• Medical oncology services
• Nonprofit cancer foundation

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain

Core offering

Fondation du Centre de Chimiothérapie Anti Cancéreuse is a Swiss foundation providing anti-cancer chemotherapy treatment services from its base in Lausanne, Switzerland. The organization operates as a specialized oncology center focused on the administration of chemotherapy for cancer patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Anti-cancer chemotherapy treatment services Specialized chemotherapy administration services for cancer patients, delivered from the foundation's facility in Lausanne, Switzerland.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• The Royal Marsden NHS Foundation Trust: UK-based specialist cancer hospital and foundation providing chemotherapy and full oncology services. Comparable as a foundation-structured, specialty cancer treatment institution in Western Europe.
• Charité Comprehensive Cancer Center: Berlin-based comprehensive cancer center within the Charité hospital system offering chemotherapy and full oncology services. Comparable as a major European academic oncology center, though larger and embedded in a general hospital.
• Gustave Roussy: Largest cancer-specialty hospital in Europe, located near Paris. Provides the full spectrum of cancer treatment including chemotherapy; a clear broader incumbent in the same clinical category with deeper resources and research integration.
• Centre hospitalier universitaire vaudois (CHUV): Lausanne's university hospital with an integrated cancer center offering chemotherapy. Most relevant local incumbent — directly co-located and likely the dominant referral, partnership, and competitive counterpart.

Direct peers

• Institut Curie: Paris-based foundation and hospital dedicated to cancer treatment and research, including chemotherapy. Highly comparable given the foundation/hospital hybrid model and oncology specialty focus.
• European Institute of Oncology (IEO): Milan-based oncology specialty hospital focused on cancer prevention, diagnosis, and treatment including chemotherapy. Directly comparable as a dedicated cancer treatment center in a neighboring European country.
• Centre Léon Bérard: French comprehensive cancer center in Lyon providing chemotherapy, surgery, and radiation oncology. Directly comparable as a specialty oncology treatment center serving regional and referral populations in a French-speaking European market.

Regional players

• Vall d'Hebron Institute of Oncology (VHIO): Barcelona-based oncology research and treatment institute providing chemotherapy and novel therapies. Comparable as a European specialty oncology center serving a regional referral base.
• National Center for Tumor Diseases (NCT): German comprehensive cancer center network providing chemotherapy and translational oncology care. Comparable as a multi-site specialty oncology treatment and research organization.
• Swiss Cancer Center (network): Network of Swiss oncology centers including CHUV-affiliated programs in Lausanne. Operates in the same Swiss healthcare market and serves as a logical collaboration and referral counterpart for a Lausanne-based chemotherapy foundation.

Market position

Strengths3 records

Weaknesses4 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/fondation-du-centre-de-chimioth%C3%A9rapie-anti-canc%C3%A9reuse

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondation du Centre de Chimiothérapie Anti Cancéreuse